Research Use Only - Not for human consumption. 18+ only.
FDA ApprovedBone & Joint HealthSubcutaneous

Pentosan Polysulfate (PPS)

Also known as: Elmiron, Fibrogamone

A sulfated polysaccharide that inhibits cartilage-degrading enzymes, promotes synovial fluid production, and reduces inflammatory mediators in joint tissue for osteoarthritis management.

Research Status

FDA Approved

FDA-approved

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Reduces joint pain and stiffness
Slows cartilage degradation progression
Increases synovial fluid viscosity
Decreases inflammatory markers in joints
Improves joint mobility and function
Supports long-term joint structure preservation

Side Effects

Gastrointestinal upset (nausea, dyspepsia, diarrhea)
CommonMild

Most common side effect. Usually resolves with continued use or by taking with food. Occurs in 10-15% of users in clinical trials.

Headache
UncommonMild

Reported in 3-5% of users. Typically mild and self-resolving.

Rash or pruritus
UncommonMild

Skin reactions reported in 1-3% of users. May indicate hypersensitivity; discontinue if severe.

Bleeding or bruising (increased)
UncommonModerate

PPS has mild anticoagulant properties. Risk increases with concurrent anticoagulants (warfarin, DOACs) or antiplatelet agents. Monitor for unusual bleeding; inform healthcare provider.

Liver enzyme elevation
RareModerate

Transient elevation of ALT/AST reported in <1% of users. Typically asymptomatic and reversible. Baseline and periodic liver function monitoring recommended.

Alopecia (hair loss)
RareMild

Rare case reports in long-term users. Mechanism unclear; may be related to cumulative polysulfate effects. Reversible upon discontinuation.

Allergic reaction (anaphylaxis)
RareSerious

Very rare but documented. Symptoms include urticaria, angioedema, dyspnea, hypotension. Seek immediate medical attention if suspected.

Dosing Reference

ParameterValue
Dose range100-300 mg
Frequency2-3x daily
TimingWith meals to improve absorption and reduce gastrointestinal upset
RouteSubcutaneous

Oral administration is standard for PPS. Injectable formulations (IM/IV) are used in some clinical settings outside the US. For research purposes, follow institutional protocols and regulatory guidance. Effects typically appear after 4-8 weeks of consistent use.

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2–8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

Molecular weight4000-6000 Da (polysaccharide polymer)
Half-life4-6 hours (oral); 24-48 hours (tissue accumulation)

Pentosan polysulfate works by inhibiting cartilage-degrading enzymes (matrix metalloproteinases and serine proteases), reducing inflammatory cytokines in synovial fluid, and enhancing the viscoelastic properties of joint fluid. It also appears to stabilize the cartilage matrix and promote chondrocyte survival, thereby slowing osteoarthritic progression.

Matrix Metalloproteinase (MMP) Inhibition

PPS suppresses MMP-2, MMP-9, and other collagenases that degrade cartilage extracellular matrix, reducing cartilage loss in osteoarthritis

Inflammatory Cytokine Reduction

Decreases production of IL-1β, TNF-α, and other pro-inflammatory mediators in synovial tissue and fluid, reducing joint inflammation

Synovial Fluid Enhancement

Increases hyaluronic acid production and improves synovial fluid viscosity and lubrication properties, reducing friction and pain

Chondrocyte Protection

Promotes chondrocyte survival and reduces apoptosis, helping preserve functional cartilage cells

  • PPS is a semi-synthetic sulfated polysaccharide derived from beechwood hemicellulose, not a peptide in the classical sense
  • Accumulates in cartilage and synovial tissue over weeks, explaining delayed onset of clinical benefit
  • Exhibits both anti-inflammatory and anti-catabolic properties in osteoarthritis models
  • Oral bioavailability is low (~3%), but systemic and local joint accumulation occurs with repeated dosing

Track your Pentosan Polysulfate (PPS) research

Free account. No credit card required.

Start Free

Browse the Research Library

40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Pentosan Polysulfate (PPS) is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.